跳至主要内容
欧盟官方标签名称词汇表条目 29693

URSODIOL

本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。

全球证据概览

所解析的身份在 13 个已索引市场数据集中的 0 个有匹配的监管证据:0 条国家记录和 0 条欧盟附件记录。下方列出每项结果和证据缺口。

0 个市场有证据
已检查的市场
13
有证据的市场
0
证据缺口
13
已解析的标识符
2

已解析的物质身份

CAS:128-13-2
EC:204-879-3
成分索引记录:
URSODIOL
化妆品功能: SKIN CONDITIONING, SKIN PROTECTING

Cholan-24-oic acid, 3,7-dihydroxy-, 3-α, 5-β, 7-β)-

1 个匹配或报告的名称
URSODIOL

跨市场监管证据

此处跟踪的 13 个市场均没有以 URSODIOL 为名的已导入规则。

这是关于本清单的陈述,而非关于法律的陈述:没有已导入的规则并不能证明某物质获准使用。规则可能以其他名称存在,或以本词汇表条目未载有的 CAS 或 EC 编号存在,或存在于尚未导入的数据集中。

化学身份与性质

CAS 128-13-2 的 PubChem 二维化学结构
CAS 128-13-2PubChem CID 31401

Ursodeoxycholic Acid

Ursodeoxycholic acid is a bile acid found in the bile of bears (Ursidae) as a conjugate with taurine. Used therapeutically, it prevents the synthesis and absorption of cholesterol and can lead to the dissolution of gallstones. It has a role as a mouse metabolite and a human metabolite. It is a C24-steroid, a dihydroxy-5beta-cholanic acid and a bile acid. It is a conjugate acid of an ursodeoxycholate. — ChEBI

IUPAC 名称
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
分子式
C24H40O4
分子量
392.6 g/mol
精确质量
392.29265975 Da
XLogP3
4.9
拓扑极性表面积
77.8 Ų
氢键供体
3
氢键受体
4
共价单元
1
已定义的立体中心
10

又称

ursodiolUDCAActigallUrsodesoxycholic acidUrso ForteDeursil3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acidAcido ursodeoxicolico
另有 16 个已报告名称
Urso 250UrsonormAcidum ursodeoxycholicum(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acidacide ursodeoxycholique724L30Y2QRDeoxyursocholic AcidNSC-683769Ursacholic AcidCHEBI:9907Cholan-24-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7beta)-Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)-3 alpha,7 beta Dihydroxy 5 beta cholan 24 oic AcidAcid, UrsacholicAcid, DeoxyursocholicAcid, Ursodeoxycholic
外部数据库标识符

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配31401

Attributed physical-property, hazard, environmental and use annotations.

  • Note: This chemical does not meet GHS hazard criteria for 4.5% (2 of 44) of reports. 来源: European Chemicals Agency (ECHA)
  • Signal: Warning 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H315 (95.5%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (95.5%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 44 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 2 of 44 reports by companies.; There are 3 notifications provided by 42 of 44 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Toxicity Summary: UDCA has been shown to have potentially toxic molecular properties. UDCA breaks down into toxic lithocholic acid. After being absorbed in the small intestine, UDCA undergoes hepatic conjugation. Beyond conjugation, UDCA does not experience further breakdown by the liver or intestinal mucosa. It becomes oxidized or reduced, yielding either 7-keto-lithocholic acid or lithocholic acid. Litcholic acid can be toxic to liver cells and even cause liver failure in those with compromised sulfation. It also leads to segmental bile duct injury, hepatocyte failure, and death. 来源: StatPearls
  • Uses: Use (kg; approx.) in Germany (2009): >10000; Use (kg) in USA (2002): 6870; Consumption (g per capita; approx.) in Germany (2009): 0.122; Consumption (g per capita) in the USA (2002): 0.0244; Excretion rate: 1; Calculated removal (%): 73.4 来源: NORMAN Suspect List Exchange

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

进一步查看此记录

在配方中筛查打开独立对比

官方来源与范围

导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。

打开官方决定